MJMarit S. Jordhoy

Marit S. Jordhoy

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Marit S. Jordhoy has a total of 15 co-authors. Here are the top co-authors by number of shared publications:

  • Peter Fayers

    Division of Applied Health Sciences, University of Aberdeen, Aberdeen, UK

    3 shared publications
  • Stein Kaasa

    Palliative Medicine Unit, Department of Radiotherapy and Oncology, University Hospital of Trondheim and Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology (NTNU), Trondheim

    3 shared publications
  • Jon Håvard Loge

    Palliative Care Unit, The Cancer Center, Ulleval University Hospital, Oslo, Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology (NTNU), Trondheim

    2 shared publications
  • Marianne Ahlner-Elmqvist

    From the Palliative Medicine Unit, Department of Oncology and Radiotherapy, University Hospital of Trondheim, and Unit of Applied Clinical Research, Norwegian University of Science and Technology, Trondheim, Norway

    2 shared publications
  • E. Brenne

    Palliative Medicine Unit, Department of Oncology, Trondheim University Hospital

    1 shared publication
  • Gerd Inger Ringdal

    Department of Psychology, Norwegian University of Science and Technology (NTNU), Trondheim

    1 shared publication

Latest Publications

  • Assessing physical functioning: a systematic review of quality of life measures developed for use in palliative care

    by Marit S. Jordhoy, Gerd Inger Ringdal, Jorunn L. Helbostad, Line Oldervoll, Jon Håvard Loge, Stein Kaasa

    Background: Physical decline is experienced by all palliative care patients and affects most aspects of life. Physical functioning (PF) is therefore a crucial domain for quality of life (Qol) assessments. The purpose of this study was to review how PF assessments are performed in Qol instruments developed for palliative careMethods: For identification of instruments, Medline searches up to April 2005 were performed using the terms (palliative care OR end of life care OR terminal care) AND quality of life AND (assessment OR instrument OR questionnaire). A total of 1326 hits were screened. Named QoL instruments were extracted from 240 abstracts and 46 relevant reports. Items assessing PF were then identified and classified according to activity domains as described by the WHO International Classification of Functioning Disability and Health.Results: Of 224 different instruments detected, 39 were identified as developed for palliative care. Of these, 11 included original PF assessments. Two were comprehensive performance status measures made for staff assessment, 9 were multidimensional tools including 2—7 PF items. The content and phrasing of items varied considerably. All instruments included some aspects of self-care, whereas the coverage of mobility, domestic, work — and leisure activities was inconsistent.Interpretation: Despite its importance, PF assessment seems to be a minor part of palliative care QoL instruments. Clear definitions and conceptualization of PF are needed, as well as a consensus on relevant aspects to include in improved instruments. Performance scales already developed should be further explored with regard to content, validity and psychometric properties. Palliative Medicine 2007;21: 673—682


  • Lack of concealment may lead to selection bias in cluster randomized trials of palliative care

    by M S Jordhùy, P M Fayers, M Ahlner-Elmqvist, S Kaasa

    Comprehensive palliative care programs are often implemented on a community level, and to evaluate such interventions, randomization by cluster (community) may be the only feasible method. In trials randomizing individual subjects, the importance of proper concealment has been stressed. In cluster randomized trials, however, concealment of individual patient allocation is often impossible. The following risk of selection bias has been given little attention. In the present study, comparing palliative care to conventional care, community health care districts were defined as clusters and randomized. The patients' treatment assignment was determined by the allocation of the cluster in which they resided, and hence predictable by their address. A biased selection based on practical considerations related to patients' diagnoses and hospital departments was suspected. To explore this, cancer diagnoses were grouped according to local tradition for sharing of treatment responsibility among hospital departments. A significant difference between trial arms in distribution of these groups was revealed and strongly supported our suspicion. The finding carries an important message to future researchers: when using cluster randomization, any evidence of selection bias should be carefully checked and reported.


  • Quality of Life in Palliative Cancer Care: Results From a Cluster Randomized Trial

    by Marit S. Jordhøy, Peter Fayers, Jon Håvard Loge, Marianne Ahlner-Elmqvist, Stein Kaasa

    PURPOSE: To assess the impact of comprehensive palliative care on patients’ quality of life. The intervention was based on cooperation between a palliative medicine unit and the community service and was compared with conventional care. PATIENTS AND METHODS: A cluster randomized trial was carried out, with community health care districts defined as the clusters. Patients from these districts who had malignant disease and survival expectancy between 2 to 9 months were entered onto the trial. The main quality-of-life end points were physical and emotional functioning, pain, and psychologic distress assessed monthly by using the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30 (EORTC QLQ-C30) questionnaire and Impact of Event scale (IES). In total, 235 intervention patients and 199 controls were included. RESULTS: During the initial 4 months of follow-up, the compliance was good (72%) and comparable among treatment groups. No significant differences on any of the quality-of-life scores were found. At later assessments and for scores that were made within 3 months before death, there was also no consistent tendency in favor of any treatment group on the main outcomes or other EORTC QLQ-C30 scales/items. CONCLUSION: A general program of palliative care may be important to ensure flexibility and to meet the needs of terminally ill patients. However, to achieve improvements on a group level of the various dimensions of quality of life, specific interventions directed toward specific symptoms or problems may have to be defined, evaluated, and included in the program.


  • A palliative-care intervention and death at home: a cluster randomised trial

    by Marit S Jordhøy, Peter Fayers, Turi Saltnes, Marianne Ahlner-Elmqvist, Magnus Jannert, Stein Kaasa


  • Open Access

    Fatigue. Measures and relation to pain

    by S. Kaasa, J. H. Loge, H. Knobel, M. S. Jordhøy, E. Brenne

    Fatigue describes reduced capacity to sustain force or power output, reduced capacity to perform multiple tasks over time and simply a subjective experience of feeling exhausted, tired, weak or having lack of energy. Pain and fatigue have several components in common, such as being subjective, prevalent in most patients with cancer and caused by multiple factors of both a physical and psychological nature. In order to explore the relationship between fatigue and pain, data from five studies were used: two random samples from the Norwegian population (n=2323 and n=1965), Hodgkin’s disease survivors (n=459), palliative care patients (n=434) and patients with bone metastases (n=94). All patients had completed one or more of the following instruments: EORTC QLQ‐C30, SF‐36 and/or Fatigue Questionnaire. The level of fatigue was much higher in the two palliative care populations (54.4 and 63.2) as compared to the normal population samples (25.0). Patients with bone metastases had significantly more pain (72.0) than the patients in the palliative care trial (47.4) and norms (20.5). In the two palliative care and bone metastases populations fatigue was almost unchanged over time, while pain was reduced. In the palliative care population a high level of fatigue (80.3) and pain (57.8) was reported 0–1 month before death. The relationship between pain, fatigue and the health‐related quality of life domains should be explored in more detail, especially in follow‐up studies in order to assess possible changes over time. In addition, the validity of the existing instruments measuring fatigue should be investigated for use in patients with advanced disease and short life expectancy.